| COMPANY COUNTRY | USA |
| STATUS | in development |
| TECHNOLOGY | Co. is developing a technique in which a DNA-binding domain & an activation domain come together, in the presence of an orally available drug, to form a transcription factor. The idea is to eventually be able to use such transcription factors to turn synthetic genes on & off in patients for gene therapy applications |
| UPDATE | 02.00 |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |